Amyloid-β Peptide-Receptor for Advanced Glycation Endproduct Interaction Elicits Neuronal Expression of Macrophage-Colony Stimulating Factor: A Proinflammatory Pathway in Alzheimer Disease
In Alzheimer disease (AD), neurons are thought to be subjected to the deleterious cytotoxic effects of activated microglia. We demonstrate that binding of amyloidbeta peptide (Aβ ) to neuronal Receptor for Advanced Glycation Endproduct (RAGE), a cell surface receptor for Aβ , induces macrophage-colo...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 94; no. 10; pp. 5296 - 5301 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences of the United States of America
13.05.1997
National Acad Sciences National Academy of Sciences The National Academy of Sciences of the USA |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In Alzheimer disease (AD), neurons are thought to be subjected to the deleterious cytotoxic effects of activated microglia. We demonstrate that binding of amyloidbeta peptide (Aβ ) to neuronal Receptor for Advanced Glycation Endproduct (RAGE), a cell surface receptor for Aβ , induces macrophage-colony stimulating factor (M-CSF) by an oxidant sensitive, nuclear factor κ B-dependent pathway. AD brain shows increased neuronal expression of M-CSF in proximity to Aβ deposits, and in cerebrospinal fluid from AD patients there was ≈ 5-fold increased M-CSF antigen (P < 0.01), compared with age-matched controls. M-CSF released by Aβ -stimulated neurons interacts with its cognate receptor, c-fms, on microglia, thereby triggering chemotaxis, cell proliferation, increased expression of the macrophage scavenger receptor and apolipoprotein E, and enhanced survival of microglia exposed to Aβ , consistent with pathologic findings in AD. These data delineate an inflammatory pathway triggered by engagement of Aβ on neuronal RAGE. We suggest that M-CSF, thus generated, contributes to the pathogenesis of AD, and that M-CSF in cerebrospinal fluid might provide a means for monitoring neuronal perturbation at an early stage in AD. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Seymour Lieberman, St. Luke’s Roosevelt Institute for Health Sciences, New York, NY |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.94.10.5296 |